Clinical Trials Browser

Phase 1/2 × Daclizumab × Dermatologic × Clear all

NCT00847106 2009-02-19

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients

Phase 1/2 Completed

Melanoma